Poland, Feb. 25 -- Neuca SA secures contract for Pharmaceutical products - Delivery of medicinal products financed by the National Health Fund under Drug Programs, Chemotherapy, Emergency Access to Dr... Read More
Poland, Feb. 25 -- Amgen Sp. z o.o. secures contract for Pharmaceutical products - Delivery of medicinal products financed by the National Health Fund under Drug Programs, Chemotherapy, Emergency Acce... Read More
Poland, Feb. 25 -- Komtur Polska sp. z o. o. secures contract for Pharmaceutical products - Delivery of medicinal products financed by the National Health Fund under Drug Programs, Chemotherapy, Emerg... Read More
Poland, Feb. 25 -- Urtica sp. z o. o. secures contract for Pharmaceutical products - Delivery of medicinal products financed by the National Health Fund under Drug Programs, Chemotherapy, Emergency Ac... Read More
Poland, Feb. 25 -- Servier Polska Services Sp. z o.o. secures contract for Pharmaceutical products - Delivery of medicinal products financed by the National Health Fund under Drug Programs, Chemothera... Read More
Poland, Feb. 25 -- GSK Services Sp. z o.o. secures contract for Pharmaceutical products - Delivery of medicinal products financed by the National Health Fund under Drug Programs, Chemotherapy, Emergen... Read More
United States, Feb. 25 -- Tagata Moana Hui Foundation secures contract for Community Infant & Maternal Health Event Coordinator Published by HT Digital Content Services with permission from Pivot... Read More
United States, Feb. 25 -- RAZOR CONSULTING SOLUTIONS, INC secures contract for Haskell Indian Health Center Lab Door Relocation Project Published by HT Digital Content Services with permission from P... Read More
Portugal, Feb. 25 -- Baxter Medico Farmaceutica, Lda. secures contract for Call For Proposals Under Framework Agreement(S) 2023/304 - Group 4 Medicines: Blood; 2023/436 - Medicines For The Central Ner... Read More
Portugal, Feb. 25 -- Cardiva Portugal Unipessoal, Lda secures contract for Call For Proposals Under Framework Agreement(S) 2023/304 - Group 4 Medicines: Blood; 2023/436 - Medicines For The Central Ner... Read More